ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism.
ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism.
复制标题
DOI:
10.1038/ncomms13016
复制
发表时间:
2016-09-28
影响因子:
16.6
通讯作者:
Oike, Yuichi
中科院分区:
文献类型:
--
作者:
Tian, Zhe;Miyata, Keishi;Kadomatsu, Tsuyoshi;Horiguchi, Haruki;Fukushima, Hiroyuki;Tohyama, Shugo;Ujihara, Yoshihiro;Okumura, Takahiro;Yamaguchi, Satoshi;Zhao, Jiabin;Endo, Motoyoshi;Morinaga, Jun;Sato, Michio;Sugizaki, Taichi;Zhu, Shunshun;Terada, Kazutoyo;Sakaguchi, Hisashi;Komohara, Yoshihiro;Takeya, Motohiro;Takeda, Naoki;Araki, Kimi;Manabe, Ichiro;Fukuda, Keiichi;Otsu, Kinya;Wada, Jun;Murohara, Toyoaki;Mohri, Satoshi;Yamashita, Jun K.;Sano, Motoaki;Oike, Yuichi
A cardioprotective response that alters ventricular contractility or promotes cardiomyocyte enlargement occurs with increased workload in conditions such as hypertension. When that response is excessive, pathological cardiac remodelling occurs, which can progress to heart failure, a leading cause of death worldwide. Mechanisms underlying this response are not fully understood. Here, we report that expression of angiopoietin-like protein 2 (ANGPTL2) increases in pathologically-remodeled hearts of mice and humans, while decreased cardiac ANGPTL2 expression occurs in physiological cardiac remodelling induced by endurance training in mice. Mice overexpressing ANGPTL2 in heart show cardiac dysfunction caused by both inactivation of AKT and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)2a signalling and decreased myocardial energy metabolism. Conversely, Angptl2 knockout mice exhibit increased left ventricular contractility and upregulated AKT-SERCA2a signalling and energy metabolism. Finally, ANGPTL2-knockdown in mice subjected to pressure overload ameliorates cardiac dysfunction. Overall, these studies suggest that therapeutic ANGPTL2 suppression could antagonize development of heart failure. Heart responds to increased workload by enlarging cardiomyocytes to preserve function, but in pathologies hypertrophy leads to heart failure. Here the authors show that ANGPTL2 activity in the heart is critical for determining beneficial vs. pathological hypertrophy via its effect on AKT-SERCA2a signaling and myocardial energy.
登录
查看更多内容
影响因子:
49.6
作者:
Bui, Anh L.;Horwich, Tamara B.;Fonarow, Gregg C.
通讯作者:
Fonarow, Gregg C.
DOI:
10.1016/j.bbrc.2004.08.083
发表时间:
2004-10-08
影响因子:
3.1
作者:
Kamon, J;Yamauchi, T;Kadowaki, T
通讯作者:
Kadowaki, T
DOI:
10.1016/j.bbrc.2003.09.154
发表时间:
2003-10-31
影响因子:
3.1
作者:
Guo, DF;Chenier, I;Inagami, T
通讯作者:
Inagami, T
影响因子:
37.8
作者:
Gielen, Stephan;Schuler, Gerhard;Adams, Volker
通讯作者:
Adams, Volker
影响因子:
20.1
作者:
Dai DF;Johnson SC;Villarin JJ;Chin MT;Nieves-Cintrón M;Chen T;Marcinek DJ;Dorn GW 2nd;Kang YJ;Prolla TA;Santana LF;Rabinovitch PS
通讯作者:
Rabinovitch PS